Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With
NCT:NCT07819474 · NOT_YET_RECRUITING
廣告
NCT IDNCT07819474
狀態NOT_YET_RECRUITING
開始日期2027-02-18
完成時間2030-08-31
SponsorM.D. Anderson Cancer Center (OTHER)
First posted
Last updated
簡要摘要
To find out if the amount of CD8 immune cells at the place where TIL cells are collected is linked to how well a patient responds to treatment.
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。